Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Petrifying: ears as hard as stone in adrenal insufficiency.
Kannenberg S, Meyhöfer S, Lehnert H, Schmid SM. Kannenberg S, et al. Lancet Diabetes Endocrinol. 2021 Jun;9(6):406. doi: 10.1016/S2213-8587(21)00112-1. Epub 2021 Apr 20. Lancet Diabetes Endocrinol. 2021. PMID: 33891887 No abstract available.
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study.
Gkalpakiotis S, Kannenberg S, Kingo K, Nada HR, Rakhmatulina MR, Lesiak A, Nicolescu AC, Darlenski R, Masri A, Zhou L, Albuquerque T, Hammad S, Almasry I. Gkalpakiotis S, et al. Among authors: kannenberg s. Dermatol Ther (Heidelb). 2024 May 4. doi: 10.1007/s13555-024-01146-8. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38702528
Slowing of Frontal β Oscillations in Atypical Parkinsonism.
Krösche M, Kannenberg S, Butz M, Hartmann CJ, Florin E, Schnitzler A, Hirschmann J. Krösche M, et al. Among authors: kannenberg s. Mov Disord. 2023 May;38(5):806-817. doi: 10.1002/mds.29378. Epub 2023 May 20. Mov Disord. 2023. PMID: 37208967
Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region.
Elezbawy B, Fasseeh AN, Fouly E, Tannira M, Dalle H, Aderian S, Abu Esba LC, Al Abdulkarim H, Ammoury A, Altawil E, Al Turaiki A, Albreiki F, Al-Haddab M, Al-Lafi A, Alowayesh M, Al-Sheikh A, Elsayed M, Elshamy A, Eshmawi M, Farag A, Hamadah I, Hedibel M, Kannenberg S, Karam R, Metni M, Raboobee N, Steinhoff M, Abaza S, Farghaly M, Kaló Z. Elezbawy B, et al. Among authors: kannenberg s. Dermatol Ther (Heidelb). 2023 Jan;13(1):131-146. doi: 10.1007/s13555-022-00857-0. Epub 2022 Nov 29. Dermatol Ther (Heidelb). 2023. PMID: 36445612 Free PMC article. Review.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
40 results